Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: A case series
Abstract Background Genetic risk variants in the hemizygous allele may influence neuropsychiatric manifestations and clinical course in 3q29 deletion carriers. Methods In‐depth phenotypic assessment in two deletion carriers included medical records, medical, genetic, psychiatric and neuropsychologic...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-09-01
|
Series: | Molecular Genetics & Genomic Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/mgg3.889 |
id |
doaj-cb8f80a9e9e447948d1ef0594ad5f478 |
---|---|
record_format |
Article |
spelling |
doaj-cb8f80a9e9e447948d1ef0594ad5f4782020-11-24T21:28:26ZengWileyMolecular Genetics & Genomic Medicine2324-92692019-09-0179n/an/a10.1002/mgg3.889Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: A case seriesEva Albertsen Malt0Katalin Juhasz1Anna Frengen2Teresia Wangensteen3Nina Merete Emilsen4Borre Hansen5Oleg Agafonov6Hilde Loge Nilsen7Department of Adult Habilitation Akershus University Hospital Lorenskog NorwayDepartment of Adult Habilitation Akershus University Hospital Lorenskog NorwayCampus Ahus, Institute of Clinical Medicine University of Oslo Oslo NorwayDepartment of Medical Genetics Oslo University Hospital Oslo NorwayDepartment of Adult Habilitation Akershus University Hospital Lorenskog NorwayDepartment of Adult Habilitation Akershus University Hospital Lorenskog NorwayBioinformatics Core Facility, Department of Core Facilities, Institute of Cancer Research Radium Hospital, Part of Oslo University Hospital Oslo NorwayCampus Ahus, Institute of Clinical Medicine University of Oslo Oslo NorwayAbstract Background Genetic risk variants in the hemizygous allele may influence neuropsychiatric manifestations and clinical course in 3q29 deletion carriers. Methods In‐depth phenotypic assessment in two deletion carriers included medical records, medical, genetic, psychiatric and neuropsychological evaluations, brain MRI scan and EEG. Blood samples were analyzed for copy number variations, and deep sequencing of the affected 3q29 region was performed in patients and seven first‐degree relatives. Risk variants were identified through bioinformatic analysis. Results One deletion carrier was diagnosed with learning difficulties and childhood autism, the other with mild intellectual disability and schizophrenia. EEG abnormalities in childhood normalized in adulthood in both. Cognitive abilities improved during adolescence in one deletion carrier. Both had microcytic, hypochromic erythrocytes and suffered from chronic pain and fatigue. Molecular and bioinformatic analyses identified risk variants in the hemizygous allele that were not present in the homozygous state in relatives in genes involved in cilia function and insulin action in the autistic individual and in synaptic function and neurosteroid transport in the subject with schizophrenia. Conclusion 3q29 deletion carriers may undergo developmental phenotypic transition and need regular medical follow‐up. Identified risk variants in the remaining hemizygous allele should be explored further in autism and schizophrenia research.https://doi.org/10.1002/mgg3.8893q29 deletionautistic disorderciliaschizophreniasynaptic function |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eva Albertsen Malt Katalin Juhasz Anna Frengen Teresia Wangensteen Nina Merete Emilsen Borre Hansen Oleg Agafonov Hilde Loge Nilsen |
spellingShingle |
Eva Albertsen Malt Katalin Juhasz Anna Frengen Teresia Wangensteen Nina Merete Emilsen Borre Hansen Oleg Agafonov Hilde Loge Nilsen Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: A case series Molecular Genetics & Genomic Medicine 3q29 deletion autistic disorder cilia schizophrenia synaptic function |
author_facet |
Eva Albertsen Malt Katalin Juhasz Anna Frengen Teresia Wangensteen Nina Merete Emilsen Borre Hansen Oleg Agafonov Hilde Loge Nilsen |
author_sort |
Eva Albertsen Malt |
title |
Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: A case series |
title_short |
Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: A case series |
title_full |
Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: A case series |
title_fullStr |
Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: A case series |
title_full_unstemmed |
Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: A case series |
title_sort |
neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: a case series |
publisher |
Wiley |
series |
Molecular Genetics & Genomic Medicine |
issn |
2324-9269 |
publishDate |
2019-09-01 |
description |
Abstract Background Genetic risk variants in the hemizygous allele may influence neuropsychiatric manifestations and clinical course in 3q29 deletion carriers. Methods In‐depth phenotypic assessment in two deletion carriers included medical records, medical, genetic, psychiatric and neuropsychological evaluations, brain MRI scan and EEG. Blood samples were analyzed for copy number variations, and deep sequencing of the affected 3q29 region was performed in patients and seven first‐degree relatives. Risk variants were identified through bioinformatic analysis. Results One deletion carrier was diagnosed with learning difficulties and childhood autism, the other with mild intellectual disability and schizophrenia. EEG abnormalities in childhood normalized in adulthood in both. Cognitive abilities improved during adolescence in one deletion carrier. Both had microcytic, hypochromic erythrocytes and suffered from chronic pain and fatigue. Molecular and bioinformatic analyses identified risk variants in the hemizygous allele that were not present in the homozygous state in relatives in genes involved in cilia function and insulin action in the autistic individual and in synaptic function and neurosteroid transport in the subject with schizophrenia. Conclusion 3q29 deletion carriers may undergo developmental phenotypic transition and need regular medical follow‐up. Identified risk variants in the remaining hemizygous allele should be explored further in autism and schizophrenia research. |
topic |
3q29 deletion autistic disorder cilia schizophrenia synaptic function |
url |
https://doi.org/10.1002/mgg3.889 |
work_keys_str_mv |
AT evaalbertsenmalt neuropsychiatricphenotypeinrelationtogenevariantsinthehemizygousallelein3q29deletioncarriersacaseseries AT katalinjuhasz neuropsychiatricphenotypeinrelationtogenevariantsinthehemizygousallelein3q29deletioncarriersacaseseries AT annafrengen neuropsychiatricphenotypeinrelationtogenevariantsinthehemizygousallelein3q29deletioncarriersacaseseries AT teresiawangensteen neuropsychiatricphenotypeinrelationtogenevariantsinthehemizygousallelein3q29deletioncarriersacaseseries AT ninamereteemilsen neuropsychiatricphenotypeinrelationtogenevariantsinthehemizygousallelein3q29deletioncarriersacaseseries AT borrehansen neuropsychiatricphenotypeinrelationtogenevariantsinthehemizygousallelein3q29deletioncarriersacaseseries AT olegagafonov neuropsychiatricphenotypeinrelationtogenevariantsinthehemizygousallelein3q29deletioncarriersacaseseries AT hildelogenilsen neuropsychiatricphenotypeinrelationtogenevariantsinthehemizygousallelein3q29deletioncarriersacaseseries |
_version_ |
1725970449596153856 |